HPV-16 L1 genes with inactivated negative RNA elements induce potent immune responses

Research output: Contribution to journalArticle

Abstract

Introduction of point mutations in the 5' end of the human papillomavirus type 16 (HPV-16) L1 gene specifically inactivates negative regulatory RNA processing elements. DNA vaccination of C57B1/6 mice with the mutated L1 gene resulted in improved immunogenicity for both neutralizing antibodies as well as for broad cellular immune responses. Previous reports on the activation of L1 by codon optimization may be explained by inactivation of the regulatory RNA elements. The modified HPV-16 L1 DNA that induced anti-HPV-16 immunity may be seen as a complementary approach to protein subunit immunization against papillomavirus.

Details

Authors
  • E Rollman
  • L Arnheim
  • B Collier
  • D Oberg
  • H Hall
  • J Klingstrom
  • Joakim Dillner
  • DV Pastrana
  • CB Buck
  • J Hinkula
  • B Wahren
  • S Schwartz
Organisations
Research areas and keywords

Subject classification (UKÄ) – MANDATORY

  • Microbiology in the medical area

Keywords

  • imiquimod, rGM-CSF, T lymphocytes, neutralization, tumor immunity, DNA vaccination, HPV-16
Original languageEnglish
Pages (from-to)182-189
JournalVirology
Volume322
Issue number1
Publication statusPublished - 2004
Publication categoryResearch
Peer-reviewedYes